CELLDEX THERAPEUTICS INC NEW filings

SEC filings by CELLDEX THERAPEUTICS INC NEW (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2014-02-06JENNISON ASSOCIATES LLCCelldex Therapeutics, Inc.3,981,8064.5%EDGAR
SC 13G/A2014-02-06JENNISON ASSOCIATES LLCCelldex Therapeutics, Inc.3,981,8064.5%EDGAR
SC 13G/A2014-01-28BlackRock Inc.Celldex Therapeutics, Inc.5,891,1766.7%EDGAR
SC 13G2013-09-10FMR LLCCelldex Therapeutics, Inc.8,269,12510.2%EDGAR
SC 13G2013-04-22SAC Capital Advisors LPCelldex Therapeutics, Inc.4,000,2554.9%EDGAR
SC 13G2013-04-05SAC Capital Advisors LPCelldex Therapeutics, Inc.3,931,3554.9%EDGAR
SC 13G2013-02-13PRUDENTIAL FINANCIAL INCCelldex Therapeutics, Inc.3,659,2265.9%EDGAR
SC 13G2013-02-11JENNISON ASSOCIATES LLCCelldex Therapeutics, Inc.3,538,9415.7%EDGAR
SC 13G2013-01-30BlackRock Inc.Celldex Therapeutics, Inc.5,361,5818.6%EDGAR
SC 13G2012-12-28Ridgeback Capital Investments L.P.Celldex Therapeutics, Inc.3,804,6466.1%EDGAR
SC 13G/A2012-03-12BlackRock Inc.Celldex Therapeutics, Inc.2,736,0104.8%EDGAR
SC 13G/A2012-02-13BlackRock Inc.Celldex Therapeutics, Inc.2,761,7846.3%EDGAR
SC 13G2011-05-26HealthCor Management, L.P.Celldex Therapeutics, Inc.2,500,0005.9%EDGAR
SC 13G2011-02-03BlackRock Inc.Celldex Therapeutics, Inc.1,887,8475.9%EDGAR
SC 13D/A2009-12-23BRISTOL MYERS SQUIBB COCelldex Therapeutics, Inc.1,487,4644.7%EDGAR
SC 13D/A2009-12-15BRISTOL MYERS SQUIBB COCelldex Therapeutics, Inc.1,892,8196.0%EDGAR
SC 13D/A2009-12-09BRISTOL MYERS SQUIBB COCelldex Therapeutics, Inc.2,474,9477.8%EDGAR
SC 13D/A2009-11-25BRISTOL MYERS SQUIBB COCelldex Therapeutics, Inc.2,889,2239.1%EDGAR
SC 13D/A2009-06-26MEDAREX INCCelldex Therapeutics, Inc.2,960,84818.7%EDGAR
SC 13G2009-05-27APAX PARTNERS EUROPE MANAGERS LTDCelldex Therapeutics, Inc.1,384,6638.8%EDGAR